AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29580733 — intervention group
Group type: EXPERIMENTAL
Intervention: Completion axillary lymph node dissection (cALND)
Number of subjects: 4331
Study 29580733 — intervention group
Group type: COMPARATOR
Intervention: Sentinel lymph node biopsy (SLNB) only
Number of subjects: 4331
Study 28335809 — intervention group
Group type: EXPERIMENTAL
Intervention: Online active learning module, direct electronic access to specialist advice, and performance feedback. Engagement strategies included multiple rounds of invitations, pre-notification, rewards, and incentives.
Number of subjects: 146
Study 25906983 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted fingers training
Number of subjects: 19
Study 25906983 — intervention group
Group type: COMPARATOR
Intervention: Control (non-assisted fingers training)
Number of subjects: 19
Study 23090678 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg daily oral ibandronate (n = 40)
Number of subjects: 110
Study 23090678 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg intermittent oral ibandronate (n = 34)
Number of subjects: 110
Study 23090678 — intervention group
Group type: COMPARATOR
Intervention: Oral placebo (n = 36)
Number of subjects: 110
Study 20380480 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosamprenavir/ritonavir (FPV/r) 1400 mg/100 mg
Number of subjects: 106
Study 20380480 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir/ritonavir (ATV/r) 300 mg/100 mg
Number of subjects: 106
Study 18652000 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard education plus addition of a video
Number of subjects: 0
Study 18652000 — intervention group
Group type: COMPARATOR
Intervention: Standard pre-chemotherapy education
Number of subjects: 0
Study 16861368 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping with caregiving class (CWC)
Number of subjects: 213
Study 16861368 — intervention group
Group type: COMPARATOR
Intervention: Enhanced support group (ESG)
Number of subjects: 213
Study 15006249 — intervention group
Group type: COMPARATOR
Intervention: Phytoestrogens
Number of subjects: 0
Study 15006249 — intervention group
Group type: COMPARATOR
Intervention: Black cohosh
Number of subjects: 0
Study 15006249 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15006249 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitors
Number of subjects: 0
Study 10832917 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron (4 microg/kg twice a day) + Naltrexone (25 mg twice a day)
Number of subjects: 20
Study 10832917 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 9093956 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual function tests (including visual acuity, contrast sensitivity, mean deviation, and color vision)
Number of subjects: 438
Study 9093956 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported vision assessment
Number of subjects: 438
Study 9093956 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionnaire on visual tasks in daily living
Number of subjects: 438
Study 8475558 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 infusion (PG group)
Number of subjects: 20
Study 8475558 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study 8475558 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 20
Study 2881461 — intervention group
Group type: EXPERIMENTAL
Intervention: HSR-902 (30 mg daily for 7 days)
Number of subjects: 170
Study 2881461 — intervention group
Group type: COMPARATOR
Intervention: Butylscopolamine bromide (60 mg daily for 7 days)
Number of subjects: 170
Study 2881461 — intervention group
Group type: EXPERIMENTAL
Intervention: HSR-902
Number of subjects: 170
Study 2881461 — intervention group
Group type: COMPARATOR
Intervention: Butylscopolamine bromide
Number of subjects: 170
Study 31408387 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflection practice
Number of subjects: 129
Study 31408387 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative learning
Number of subjects: 129
Study 31408387 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive acquisition of knowledge
Number of subjects: 129
Study 31408387 — intervention group
Group type: COMPARATOR
Intervention: Reflection practice, Collaborative learning, Passive acquisition of knowledge
Number of subjects: 129
Study 29304848 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ferric carboxymaltose (FCM)
Number of subjects: 200
Study 29304848 — intervention group
Group type: COMPARATOR
Intervention: Iron sucrose (IS)
Number of subjects: 200
Study 27142448 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea (2 g/day, containing 220.2 mg of catechins)
Number of subjects: 33
Study 27142448 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.0 mg of catechins)
Number of subjects: 33
Study 24522178 — intervention group
Group type: EXPERIMENTAL
Intervention: efavirenz 400 mg
Number of subjects: 630
Study 24522178 — intervention group
Group type: COMPARATOR
Intervention: efavirenz 600 mg
Number of subjects: 630
Study 22018092 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention (1.65 MJ expended on day 1)
Number of subjects: 14
Study 22018092 — intervention group
Group type: COMPARATOR
Intervention: Control (resting conditions)
Number of subjects: 14
Study 21313892 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral clonidine (0.2 mg)
Number of subjects: 274
Study 21313892 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 274
Study 17468586 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia group (11% O2 on days 1-7 and 10% O2 on days 8-15)
Number of subjects: 20
Study 17468586 — intervention group
Group type: COMPARATOR
Intervention: Control group (compressed air)
Number of subjects: 20
Study 17468586 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia group
Number of subjects: 20
Study 17468586 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study 14965404 — intervention group
Group type: EXPERIMENTAL
Intervention: Outreach visits to promote national guidelines on acute low back pain, access to fast-track physiotherapy, and a triage service for patients with persistent symptoms.
Number of subjects: 2187
Study 14965404 — intervention group
Group type: COMPARATOR
Intervention: Control group (no outreach visits, standard care).
Number of subjects: 2187
Study 11823923 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylcholinesterase Inhibitors (AChEI)
Number of subjects: 0
Study 9817530 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential therapy with zidovudine, didanosine and zalcitabine
Number of subjects: 53
Study 9817530 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy with zidovudine
Number of subjects: 53
Study 7711990 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural meperidine 1 mg kg‐1
Number of subjects: 20
Study 7711990 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural pentazocine 0.3 mg kg‐1
Number of subjects: 20
Study 2674395 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial agent delivered by an oral irrigating device
Number of subjects: 66
Study 2674395 — intervention group
Group type: COMPARATOR
Intervention: Control (half mouth dental prophylaxis)
Number of subjects: 66
Study 386307 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 22
Study 386307 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 31259755 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5% lidocaine
Number of subjects: 48
Study 31259755 — intervention group
Group type: COMPARATOR
Intervention: 0.5% levobupivacaine
Number of subjects: 48
Study 31106377 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampicin plus β‐lactam antibiotics
Number of subjects: 41
Study 31106377 — intervention group
Group type: COMPARATOR
Intervention: β‐lactam antibiotics only
Number of subjects: 41
Study 27614097 — intervention group
Group type: EXPERIMENTAL
Intervention: Very Low Nicotine Content (VLNC) cigarettes (VLNC1)
Number of subjects: 136
Study 27614097 — intervention group
Group type: EXPERIMENTAL
Intervention: Very Low Nicotine Content (VLNC) cigarettes (VLNC2)
Number of subjects: 136
Study 26135349 — intervention group
Group type: EXPERIMENTAL
Intervention: Butter intake
Number of subjects: 47
Study 26135349 — intervention group
Group type: COMPARATOR
Intervention: Olive oil intake
Number of subjects: 47
Study 26135349 — intervention group
Group type: COMPARATOR
Intervention: Habitual diet (run-in period)
Number of subjects: 47
Study 23443901 — intervention group
Group type: EXPERIMENTAL
Intervention: Interfascial bupivacaine administration
Number of subjects: 60
Study 23443901 — intervention group
Group type: COMPARATOR
Intervention: Suprafascial bupivacaine administration
Number of subjects: 60
Study 21314871 — intervention group
Group type: COMPARATOR
Intervention: Duloxetine treatment
Number of subjects: 5111
Study 21314871 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine treatment for fibromyalgia and CLBP
Number of subjects: 5111
Study 21314871 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine treatment for DPNP
Number of subjects: 5111
Study 20108851 — intervention group
Group type: EXPERIMENTAL
Intervention: Scapular Mobilization (SM)
Number of subjects: 39
Study 20108851 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 39
Study 20108851 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 39
Study 17824890 — intervention group
Group type: EXPERIMENTAL
Intervention: Early loading of mandibular implant overdentures delivered 1 week after surgery
Number of subjects: 20
Study 17824890 — intervention group
Group type: COMPARATOR
Intervention: Conventional mandibular prostheses converted to mandibular implant overdentures 3 months after surgery
Number of subjects: 20
Study 17824890 — intervention group
Group type: EXPERIMENTAL
Intervention: Prosthodontic maintenance of the mandibular implant overdentures in the first year
Number of subjects: 20
Study 15888499 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Stenting (DS)
Number of subjects: 202
Study 15888499 — intervention group
Group type: COMPARATOR
Intervention: Pre-dilatation (PD)
Number of subjects: 202
Study 11815428 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosinopril 20 mg
Number of subjects: 96
Study 11815428 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosinopril 40 mg
Number of subjects: 96
Study 11815428 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine 5 mg
Number of subjects: 96
Study 11815428 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine 10 mg
Number of subjects: 96
Study 11815428 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 96
Study 11815428 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosinopril
Number of subjects: 96
Study 10730079 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative epidural morphine 2 mg at T 6‐7 and 2 mg at L 3‐4
Number of subjects: 30
Study 10730079 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous thoracic epidural infusion of 1% lidocaine (lidocaine group, n = 15)
Number of subjects: 30
Study 10730079 — intervention group
Group type: COMPARATOR
Intervention: Continuous thoracic epidural infusion of normal saline solution (control group, n = 15)
Number of subjects: 30
Study 7854537 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbidopa/levodopa
Number of subjects: 11
Study 7854537 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbidopa/levodopa plus selegiline
Number of subjects: 11
Study 1763311 — intervention group
Group type: EXPERIMENTAL
Intervention: hybrid composite P‐30
Number of subjects: 15
Study 1763311 — intervention group
Group type: COMPARATOR
Intervention: dentine adhesive composite systems (5 different types)
Number of subjects: 15
Study 7357821 — intervention group
Group type: EXPERIMENTAL
Intervention: Elemental diet supplements
Number of subjects: 0
Study 7357821 — intervention group
Group type: COMPARATOR
Intervention: Control group (no elemental diet)
Number of subjects: 0
Study 31268369 — intervention group
Group type: EXPERIMENTAL
Intervention: Tildrakizumab 100 mg
Number of subjects: 352
Study 30576888 — intervention group
Group type: EXPERIMENTAL
Intervention: Sagittal plastinated slices (SPS)
Number of subjects: 0
Study 30576888 — intervention group
Group type: COMPARATOR
Intervention: Conventional anatomy teaching resources (dry bones and whole cadaveric feet)
Number of subjects: 0
Study 28747220 — intervention group
Group type: EXPERIMENTAL
Intervention: HALS-CME (hand-assisted laparoscopic surgery with complete mesocolic excision, D3 lymphadenectomy, and total 'no-touch' isolation technique)
Number of subjects: 0
Study 28747220 — intervention group
Group type: EXPERIMENTAL
Intervention: LAP-CME (laparoscopic surgery with complete mesocolic excision, D3 lymphadenectomy, and total 'no-touch' isolation technique)
Number of subjects: 0
Study 28747220 — intervention group
Group type: COMPARATOR
Intervention: cLAP (conventional laparoscopic surgery with complete mesocolic excision and D3 lymphadenectomy)
Number of subjects: 0
Study 28747220 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative outcomes
Number of subjects: 0
Study 25965082 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose prophylactic corticosteroid (PCS) starting dose 15 mg/day of prednisolone for 6 weeks (PCS-On group)
Number of subjects: 295
Study 25965082 — intervention group
Group type: COMPARATOR
Intervention: No prophylactic corticosteroid (PCS-Off group)
Number of subjects: 295
Study 25965082 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (PCS-On and PCS-Off)
Number of subjects: 295
Study 25965082 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroid-stimulating antibody
Number of subjects: 295
Study 25965082 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical activity score (≥1 vs 0)
Number of subjects: 295
Study 23937476 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory electrical stimulation (e-stim) at 75% of motor threshold
Number of subjects: 20
Study 23937476 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor electrical stimulation (e-stim) at motor threshold
Number of subjects: 20
Study 21279975 — intervention group
Group type: COMPARATOR
Intervention: Standard PDT (10‐minute 6 mg/mq2 verteporfin infusion; treatment at 15 min; 50 J/cm2; 83 s)
Number of subjects: 20
Study 21279975 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus PDT (6 mg/mq2 verteporfin infusion bolus in 1 min; treatment at 5 min; 100 J/cm2; 166 s)
Number of subjects: 20
Study 21279975 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus PDT
Number of subjects: 20
Study 21279975 — intervention group
Group type: COMPARATOR
Intervention: Standard PDT
Number of subjects: 20
Study 19104168 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngoscope group (rigid laryngoscope-assisted insertion)
Number of subjects: 80
Study 19104168 — intervention group
Group type: COMPARATOR
Intervention: Conventional group (blind insertion)
Number of subjects: 80
Study 17551418 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplement
Number of subjects: 35
Study 15110440 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based training
Number of subjects: 0
Study 15110440 — intervention group
Group type: COMPARATOR
Intervention: Instructor-led training
Number of subjects: 0
Study 11240080 — intervention group
Group type: EXPERIMENTAL
Intervention: Face‐to‐face healing for 30 min per week for 8 weeks
Number of subjects: 120
Study 11240080 — intervention group
Group type: COMPARATOR
Intervention: Simulated face‐to‐face healing for 30 min per week for 8 weeks
Number of subjects: 120
Study 11240080 — intervention group
Group type: EXPERIMENTAL
Intervention: Distant healing for 30 min per week for 8 weeks
Number of subjects: 120
Study 11240080 — intervention group
Group type: COMPARATOR
Intervention: No healing for 30 min per week for 8 weeks
Number of subjects: 120
Study 10920971 — intervention group
Group type: EXPERIMENTAL
Intervention: Zudan
Number of subjects: 30
Study 10920971 — intervention group
Group type: COMPARATOR
Intervention: Zofran
Number of subjects: 30
Study 8083077 — intervention group
Group type: COMPARATOR
Intervention: Cohort 1: Three cycles of radiotherapy alone (48.6 Gy)
Number of subjects: 0
Study 8083077 — intervention group
Group type: EXPERIMENTAL
Intervention: Cohort 2: Three completed cycles of chemotherapy and radiotherapy
Number of subjects: 0
Study 8083077 — intervention group
Group type: EXPERIMENTAL
Intervention: Cohort 3: Three completed cycles and a fourth radiotherapy course (64.8 Gy)
Number of subjects: 0
Study 2634468 — intervention group
Group type: COMPARATOR
Intervention: Water-soluble contrast medium (WSCM)
Number of subjects: 109
Study 2634468 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-soluble contrast medium (WSCM) + oil-soluble contrast medium (OSCM)
Number of subjects: 109
Study 1271224 — intervention group
Group type: EXPERIMENTAL
Intervention: Close interpersonal distance (confederate standing immediately adjacent)
Number of subjects: 60
Study 1271224 — intervention group
Group type: COMPARATOR
Intervention: Moderate interpersonal distance (one urinal removed)
Number of subjects: 60
Study 1271224 — intervention group
Group type: COMPARATOR
Intervention: No interpersonal distance (confederate absent)
Number of subjects: 60
Study 1271224 — intervention group
Group type: EXPERIMENTAL
Intervention: Close interpersonal distance
Number of subjects: 60
Study 31386937 — intervention group
Group type: EXPERIMENTAL
Intervention: High anticholinergic burden (ARS ≥ 2)
Number of subjects: 118750
Study 27615555 — intervention group
Group type: EXPERIMENTAL
Intervention: Vosaroxin combined with cytarabine
Number of subjects: 0
Study 27615555 — intervention group
Group type: COMPARATOR
Intervention: Cytarabine alone
Number of subjects: 0
Study 26277524 — intervention group
Group type: EXPERIMENTAL
Intervention: HBO therapy at 0.175 MPa
Number of subjects: 93
Study 26277524 — intervention group
Group type: EXPERIMENTAL
Intervention: HBO therapy at 0.2 MPa
Number of subjects: 93
Study 26277524 — intervention group
Group type: COMPARATOR
Intervention: Control group (no HBO therapy)
Number of subjects: 93
Study 26277524 — intervention group
Group type: EXPERIMENTAL
Intervention: HBO therapy at 0.175 MPa and 0.2 MPa
Number of subjects: 93
Study 23607238 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous blood transfusion (n = 55)
Number of subjects: 112
Study 23607238 — intervention group
Group type: COMPARATOR
Intervention: Allogeneic blood transfusion (n = 57)
Number of subjects: 112
Study 21501481 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy of lower intensity with CMF
Number of subjects: 327
Study 21501481 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with CAF
Number of subjects: 327
Study 21501481 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonal therapy alone following surgery and/or radiation therapy
Number of subjects: 327
Study 21501481 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 327
Study 21501481 — intervention group
Group type: EXPERIMENTAL
Intervention: Molecular subtypes correlation with recurrence risk
Number of subjects: 327
Study 19452526 — intervention group
Group type: EXPERIMENTAL
Intervention: Intake of fresh meat
Number of subjects: 120852
Study 19452526 — intervention group
Group type: EXPERIMENTAL
Intervention: Intake of processed meat
Number of subjects: 120852
Study 19452526 — intervention group
Group type: EXPERIMENTAL
Intervention: Intake of fish
Number of subjects: 120852
Study 19452526 — intervention group
Group type: EXPERIMENTAL
Intervention: Intake of eggs
Number of subjects: 120852
Study 19452526 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake of total fat
Number of subjects: 120852
Study 19452526 — intervention group
Group type: EXPERIMENTAL
Intervention: Different types of fat
Number of subjects: 120852
Study 16822585 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary hypertension patients
Number of subjects: 9
Study 16822585 — intervention group
Group type: COMPARATOR
Intervention: Controls (N=8)
Number of subjects: 9
Study 14687052 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal sacro‐colpopexy
Number of subjects: 82
Study 11123197 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% lipid (2 kcal/min) + vehicle
Number of subjects: 9
Study 11123197 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% lipid + duodenal 0.75% benzocaine
Number of subjects: 9
Study 11123197 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% lipid + jejunal 0.75% benzocaine
Number of subjects: 9
Study 11123197 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline + vehicle
Number of subjects: 9
Study 9429014 — intervention group
Group type: EXPERIMENTAL
Intervention: Swimmers
Number of subjects: 459
Study 9429014 — intervention group
Group type: EXPERIMENTAL
Intervention: Male national standard swimmers (n = 38)
Number of subjects: 459
Study 9429014 — intervention group
Group type: COMPARATOR
Intervention: Years of swimming training controlled
Number of subjects: 459
Study 9429014 — intervention group
Group type: COMPARATOR
Intervention: Land based athletes and sedentary controls
Number of subjects: 459
Study 8328375 — intervention group
Group type: EXPERIMENTAL
Intervention: Nisoldipine therapy
Number of subjects: 115
Study 3087307 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime sodium at a dosage of 12 g/day
Number of subjects: 187
Study 3087307 — intervention group
Group type: COMPARATOR
Intervention: Nafcillin sodium and tobramycin sulfate
Number of subjects: 187
Study 3087307 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime sodium
Number of subjects: 187
Study 31994953 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged minimal enteral nutrition (MEN)
Number of subjects: 199
Study 31994953 — intervention group
Group type: COMPARATOR
Intervention: Early feeding advancement
Number of subjects: 199
Study 30120168 — intervention group
Group type: EXPERIMENTAL
Intervention: Minilaparotomy performed by trained Clinical Officers (COs)
Number of subjects: 1970
Study 30120168 — intervention group
Group type: COMPARATOR
Intervention: Minilaparotomy performed by trained Assistant Medical Officers (AMOs)
Number of subjects: 1970
Study 27189825 — intervention group
Group type: EXPERIMENTAL
Intervention: OPA-15406 1%
Number of subjects: 121
Study 27189825 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 121
Study 24087989 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH; nadroparin) for 1 week
Number of subjects: 66
Study 24087989 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH; nadroparin)
Number of subjects: 66
Study 24087989 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (Control group)
Number of subjects: 66